BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 33891302)

  • 1. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
    Muscogiuri G; Barrea L; Faggiano F; Maiorino MI; Parrillo M; Pugliese G; Ruggeri RM; Scarano E; Savastano S; Colao A;
    J Endocrinol Invest; 2021 Oct; 44(10):2057-2070. PubMed ID: 33891302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
    Angulo MA; Butler MG; Cataletto ME
    J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.
    Muscogiuri G; Formoso G; Pugliese G; Ruggeri RM; Scarano E; Colao A;
    Rev Endocr Metab Disord; 2019 Jun; 20(2):239-250. PubMed ID: 31065942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches.
    Butler MG; Manzardo AM; Forster JL
    Curr Pediatr Rev; 2016; 12(2):136-66. PubMed ID: 26592417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of obesity in Prader-Willi syndrome.
    Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
    Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.
    Butler MG; Miller JL; Forster JL
    Curr Pediatr Rev; 2019; 15(4):207-244. PubMed ID: 31333129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine manifestations and management of Prader-Willi syndrome.
    Emerick JE; Vogt KS
    Int J Pediatr Endocrinol; 2013 Aug; 2013(1):14. PubMed ID: 23962041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prader-Willi syndrome: an update on obesity and endocrine problems.
    Kim SJ; Cho SY; Jin DK
    Ann Pediatr Endocrinol Metab; 2021 Dec; 26(4):227-236. PubMed ID: 34991300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the clinical and genetic aspects of Prader-Willi syndrome.
    Jin DK
    Korean J Pediatr; 2011 Feb; 54(2):55-63. PubMed ID: 21503198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review.
    Napolitano L; Barone B; Morra S; Celentano G; La Rocca R; Capece M; Morgera V; Turco C; Caputo VF; Spena G; Romano L; De Luca L; Califano G; Collà Ruvolo C; Mangiapia F; Mirone V; Longo N; Creta M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity management in Prader-Willi syndrome: current perspectives.
    Crinò A; Fintini D; Bocchini S; Grugni G
    Diabetes Metab Syndr Obes; 2018; 11():579-593. PubMed ID: 30323638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
    Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
    J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation.
    Madeo SF; Zagaroli L; Vandelli S; Calcaterra V; Crinò A; De Sanctis L; Faienza MF; Fintini D; Guazzarotti L; Licenziati MR; Mozzillo E; Pajno R; Scarano E; Street ME; Wasniewska M; Bocchini S; Bucolo C; Buganza R; Chiarito M; Corica D; Di Candia F; Francavilla R; Fratangeli N; Improda N; Morabito LA; Mozzato C; Rossi V; Schiavariello C; Farello G; Iughetti L; Salpietro V; Salvatoni A; Giordano M; Grugni G; Delvecchio M
    Front Endocrinol (Lausanne); 2024; 15():1382583. PubMed ID: 38737552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of thyroid function with genetic subtypes and treatment with growth hormone in Prader-Willi syndrome.
    Schmok T; Surampalli A; Khare M; Zandihaghighi S; Baghbaninogourani R; Patolia B; Gold JA; Naidu A; Cassidy SB; Kimonis VE
    Am J Med Genet A; 2024 Jun; ():e63724. PubMed ID: 38837660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteins and proteases of Prader-Willi syndrome: a comprehensive review and perspectives.
    Basak S; Basak A
    Biosci Rep; 2022 Jun; 42(6):. PubMed ID: 35621394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case of 15q26-qter deletion associated with a Prader-Willi phenotype.
    Santos JFD; Acosta AX; Scheibler GG; Pitanga PML; Alves ES; Meira JGC; Zanardo ÉA; Kulikowski LD; Lima RLLF; Carvalho AFL
    Eur J Med Genet; 2020 Aug; 63(8):103955. PubMed ID: 32473228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prader-Willi syndrome.
    Cassidy SB; Driscoll DJ
    Eur J Hum Genet; 2009 Jan; 17(1):3-13. PubMed ID: 18781185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index.
    Butler MG; Matthews NA; Patel N; Surampalli A; Gold JA; Khare M; Thompson T; Cassidy SB; Kimonis VE
    Am J Med Genet A; 2019 Sep; 179(9):1826-1835. PubMed ID: 31313492
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.